文献速递慢性肾脏病血液净化与透析

非洲裔美国人中的肾脏病:群体视角

Kidney Disease Among African Americans: A Population Perspective.
PubMed 文献 · Am J Kidney Dis · 2018-01-01

本文从群体视角综述非洲裔美国人中慢性肾脏病(CKD)及终末期肾病的种族差异,涉及临床、社会经济、文化因素及健康社会决定因素。非洲裔美国人需肾脏替代治疗的可能性是非西班牙裔白人的3倍,但相关差异在多数CKD方面正逐渐缩小。

要点

  • 非洲裔美国人需肾脏替代治疗的可能性为非西班牙裔白人的3倍。
  • CKD差异与临床、社会经济、文化因素及健康社会决定因素相关。
  • CKD及透析质量方面的差异在多数方面正逐渐缩小。

核心结论

  • 非洲裔美国人肾脏替代治疗需求显著高于非西班牙裔白人,但CKD相关差异在多数方面正逐渐缩小。

研究设计与样本

  • 本文为群体视角的综述,检索范围未在摘要中报告。

主要发现

  • 非洲裔美国人需肾脏替代治疗的可能性是非西班牙裔白人的3倍。
  • CKD差异与临床、社会经济、文化因素及健康社会决定因素相关。
  • 患者结局有所改善,CKD及CKD危险因素多数方面的差异正在缩小。
  • 透析患者质量指标也有广泛数据表明类似改善。

临床怎么用

  • 临床应关注非洲裔美国人CKD高危人群的早期识别与差异干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

End-stage kidney disease and earlier stages of chronic kidney disease (CKD) represent one of the most dramatic examples of racial/ethnic disparities in health in our nation. African Americans are 3 times more likely to require renal replacement therapy then their non-Hispanic white counterparts. This article describes CKD-related disparities linked to a variety of clinical, socioeconomic, and cultural factors, as well as to select social determinants of health that are defined by social positioning and often by race within the United States. Our advancing understanding of these issues has led to improvements in patient outcomes and is narrowing the gap in disparities across most aspects of CKD and CKD risk factors. There are also extensive data indicating similar improvements in quality measures for patients on dialysis therapy. This article also reviews the state of CKD in African Americans from a population perspective and provides recommendations for the way forward.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Laster M, Shen JI, Norris KC, et al. Kidney Disease Among African Americans: A Population Perspective. Am J Kidney Dis. 2018. PMID: 30343720. doi:10.1053/j.ajkd.2018.06.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。